India’s wellness and beauty sector saw at least funding announcements on May 4, with menstrual hygiene brand HealthFab closing a ₹20 crore Series A and skincare brand CHOSEN raising ₹47 crore ($5 million) in its Series A round — together signalling growing investor appetite for purpose-driven, category-defining consumer health brands.
HealthFab raises ₹20 crore to reach 50 lakh women
Bengaluru-based HealthFab, the menstrual hygiene startup that gained national attention after appearing on Shark Tank India, has raised ₹20 crore in a Series A funding round led by Atomic Capital. The brand will use the capital to expand its period care product portfolio, scale distribution across quick commerce channels, and increase manufacturing capacity.
Founded in 2019 by Kiriti Acharjee, Sourav Chakrabarty, and Satyajit Chakraborty, HealthFab is best known for GoPadFree — a reusable, leak-proof cotton period underwear designed as a sustainable alternative to disposable pads. The company claims to have acquired over 5 lakh customers and reports threefold year-on-year revenue growth.
Co-founder and CEO Kiriti Acharjee said: “It took us five years to earn the trust of five lakh women. We focused on one problem until we solved it completely. Now, we want to address the entire menstrual cycle, including fatigue, sleep issues and pain.”
The company aims to reach 50 lakh women over the next three years and grow revenue threefold in the next 12 months, expanding into general trade alongside its direct-to-consumer business.
CHOSEN raises ₹47 crore to take Indian skin science global
Chennai-based CHOSEN has raised ₹47 crore ($5 million) in a Series A round led by Fireside Ventures, with participation from BOLD, Alkemi Growth Capital, and angel investors including Avnish Anand, Chandan Asokan, KC Nischal, Punit Saraogi, Nishita Ranka, and Mikki Singh. The round follows a $1.2 million angel raise in 2024.
Founded in 2020 by Renita Rajan, CHOSEN builds clinically validated skincare products specifically formulated for melanin-rich, Indian skin, targeting pigmentation, skin texture, contour, and hair ageing. The brand operates a clinic-to-consumer model, with products prescribed across more than 2,000 clinics in India. Around 70% of revenue comes from repeat customers, primarily women between 30 and 50.
The fresh capital will strengthen R&D, expand its clinically validated product pipeline, and fund global expansion into “skin of colour” markets in Latin America and East Asia.
